Valneva confirmed its outlook for 2025, including expectations for total revenue between 180 million and 190 million euros. Total revenue last year was approximately 170 million euros. With Pfizer, ...

Pfizer: The drugmaker has launched its next-generation 20-valent pneumococcal conjugate vaccine (PCV20) in India for adult immunisation against 20 serotypes responsible for most invasive and ...